As PGCC cells are endowed with reduced proliferative rate in vitro combined with accelerated tumor growth capacity (Zhang et al., 2014), the induction of HIF1α protein levels in the CSL-deficient cells may underlie their enhanced growth rates, invasive capacity, and accelerated tumor growth. Here, HIF1A is linked to neoplasm.